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Abstract
Liposomes can be used for the intracellular delivery of drugs into macrophages. Previously, we developed a liposome-
mediated macrophage ‘suicide’ technique based on the intraphagocytic accumulation of the liposomally delivered
bisphosphonate clodronate. Later we found that the diamidine propamidine is even more effective in this approach. In the
present study it is shown that liposome-encapsulated 4P,6-diamidino-2-phenylindole (L-DAPI), another well known DNA-
binding diamidine, is the most effective drug in killing liver macrophages (Kupffer cells), when intravenously administered in
rat. Compared to liposome-encapsulated propamidine (L-propamidine) it showed about 10-fold more activity on a molar
basis. Furthermore, L-DAPI was found to induce cell death by inducing apoptosis. The structurally strongly related
phenanthridinium salts ethidium bromide (EB) and propidium iodide (PI) exert marked differences in their efficacy. Whereas
liposome-encapsulated PI (L-PI) was about 5 times more active in killing macrophages than L-propamidine, liposome-
encapsulated EB (L-EB) showed a strongly reduced activity (10 times less than L-PI). As is shown here, PI remains mainly
encapsulated in liposomes, while substantial amounts of EB leak out of liposomes. This may very well explain the differences
in in vivo activity between L-EB and L-PI. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
The liposome-encapsulated bisphosphonate clod-
ronate can be used for in vivo depletion of macro-
phages from various organs and tissues. This so-
called liposome-mediated macrophage suicide ap-
proach is widely applied in order to reveal macro-
phage functions and to obtain transient suppression
of macrophage activity [1^4]. Whereas various other
liposome-encapsulated bisphosphonates were inac-
tive in this approach [5], we have recently shown
that the liposome-encapsulated diamidine propami-
dine was about 5 times more e⁄cacious than clod-
ronate [6]. In general, working with L-drugs that are
more e¡ective could lead to a reduction of amounts
of liposomal components used in experimental mod-
els. Furthermore, compounds like the diamidines
show considerable toxic e¡ects in vivo, despite their
0005-2736 / 98 / $19.00 ß 1998 Elsevier Science B.V. All rights reserved.
PII: S 0 0 0 5 - 2 7 3 6 ( 9 8 ) 0 0 0 8 9 - 3
Abbreviations: DAPI, 4P,6-diamidino-2-phenylindole; EB,
ethidium bromide; PI, propidium iodide; L-drug, liposome-en-
capsulated drug (L-DAPI, L-EB or L-PI)
* Corresponding author. Fax: +31 (20) 4448081;
E-mail : jaj.bakker.cell@med.vu.nl
BBAMEM 77410 1-8-98
Biochimica et Biophysica Acta 1373 (1998) 93^100
antimicrobial, antitumoral, and antiviral activities
[10]. Concerning these e¡ects, it may be obvious
that a drug-delivery approach such as used in the
liposome-mediated macrophage ‘suicide’ technique
could be very suitable.
It was further shown that both intracellular clod-
ronate and intracellular propamidine induce apop-
totic cell death in macrophages [7,8]. Contrary to
clodronate, propamidine is known to bind DNA in
the minor groove and its cellular activity may well be
related to this characteristic [9^12].
In this study we examined whether another well
known minor groove binding diamidine, i.e. DAPI
[13], is also e⁄cacious in the liposome-mediated mac-
rophage suicide approach. DAPI is frequently used
as a dye for staining of DNA. Two other compounds
that are £uorescent upon binding to DNA are ethi-
dium bromide and propidium iodide. These phenan-
thridiniums are structurally well related and bind
DNA in an intercalative fashion but not in the minor
groove [14]. We determined their activities in the
above mentioned approach. Also, we examined
whether apoptosis is the main mechanism of cell
death after internalization of L-DAPI, L-EB or L-
PI in an in vitro assay, using the macrophage-like
RAW264 cells.
2. Materials and methods
2.1. Preparation and administration of liposomes
Multilamellar liposomes were prepared as de-
scribed previously [1]. Brie£y, 86 mg phosphatidyl-
choline (Lipoid E PC, Lipoid, Ludwigshafen, Ger-
many) and 8 mg cholesterol (Sigma, St. Louis,
MO, USA) were dissolved (molar ratio 6:1 phospha-
tidylcholine/cholesterol) in 20 ml chloroform in a
round-bottom £ask. The lipid ¢lm formed on the
interior of the £ask after rotary evaporation under
reduced pressure at 37‡C was dispersed in 10 ml
saline solutions of propamidine (Rho“ne-Poulenc
Rorer, Dagenham, UK), DAPI, EB or PI (all three
purchased from Sigma at various concentrations.
Liposomes were not extruded. Finally, the liposomes
were resuspended in 4 ml PBS. We estimated their
size to be in the range of 0.2^6 Wm.
In vivo each concentration of the L-drugs used
was tested on a group of four male Wag/Rij rats
(aged 9 weeks, approx. 220 g) by an intravenous
injection in the tail vein of a 1.5 ml liposome suspen-
sion. An untreated group of four rats was taken as a
control.
In culture each L-drug was tested in a ratio of 1:10
as volume of liposome suspension to total volume of
culture medium.
2.2. Immunohistochemistry
Forty-eight hours after administration of the lipo-
somes the rats were killed, livers removed, frozen in
liquid nitrogen, and stored at 380‡C. Frozen sec-
tions were stained for the presence or absence of
Kup¡er cells. Staining of the Kup¡er cells was per-
formed as described earlier [6,15]. In short, frozen
tissues were cut on a cryostat and sections of 8 Wm
thickness were picked up on glass slides. After air-
drying sections were ¢xed in anhydrous acetone and
a two-step immunoperoxidase method using the
monoclonal antibody ED2 [16] for detection of
Kup¡er cells in the rat liver was carried out. ED2
was diluted 1:250 with a 0.1% BSA/PBS solution. A
1:300 dilution of rabbit anti-mouse Ig-peroxidase in
0.1% BSA/PBS solution was used, which could be
visualized with 3,3P-diaminobenzidinetetrahydro-
chloride (DAB; Sigma).
Since ethidium, propidium and DAPI are all £uo-
rescent compounds, uptake of the liposome-encapsu-
lated form of these drugs by liver cells could be vis-
ualized on 8 Wm sections with a Zeiss £uorescence
microscope.
2.3. Determination of Kup¡er cells
Numbers of Kup¡er cells were determined using a
normal light microscope (200U magni¢cation) as de-
scribed previously [6]. Per liver a total area of 3 mm2
(in two di¡erent sections) was screened for ED2-pos-
itive Kup¡er cells. The mean number of Kup¡er cells
in the group of four untreated rats (control group)
was taken as 100%.
2.4. Cell cultures
The macrophage-like cell line RAW264 [17] was
cultured in 75 cm2 tissue culture £asks with RPMI
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1640 medium (Gibco, New York, USA) containing
penicillin-streptomycin (50^50 U/ml) (Gibco) and
10% newborn calf serum. At 20 h, 48 h or 72 h after
addition of liposome-encapsulated drugs cells were
harvested in 10 mM EDTA/RPMI and washed
with fresh medium. In case of addition of free drugs,
cells were harvested in 5 mM EDTA/PBS and
washed with PBS. Cell viability was determined by
trypan blue staining. For leakage studies, after 1 h
(L-EB) or 24 h (L-PI, L-DAPI) incubation of L-drug
in RPMI 1640 medium, liposomes were removed by
centrifugation (22 000Ug) twice and free drug was
measured spectroscopically (VEB = 280 nm; VPI = 302
nm; VDAPI = 346 nm).
2.5. Determination of apoptotic cell death
To determine whether apoptosis occurred in
RAW264 cells we made use of two methods. Firstly,
we measured the appearance of a sub-G1 peak [18]
by £ow cytometry, using a Becton Dickinson FACS-
can. This method has been used before to determine
apoptosis in RAW264 cells and peritoneal macro-
phages after treatment with liposome-encapsulated
clodronate [7]. In short, 2U106 cells were ¢xed in
70% ethanol at 4‡C for at least 24 h, permeabilized
in 0.1% NP40/PBS at 0‡C for 10 min and incubated
for 30 min at 0‡C in 50 Wg/ml propidium iodide
(Calbiochem) in PBS for DNA staining with the ad-
dition of 25 Wg/ml RNase A (Sigma). Secondly, we
analyzed the oligonucleosomal DNA fragmentation
by gel electrophoresis [7]. Brie£y, cells and debris
were taken up in 5 ml lysine bu¡er (10 mM Tris-
HCl (pH 7.5), 100 mM NaCl, 1 mM EDTA, 1%
SDS, 1 mg proteinase K (Sigma)). After extraction
with 1:1 (v/v) phenol/chloroform and pure chloro-
form, the aqueous phase was collected and incubated
with 100 Wg RNase A for 1 h at 20‡C. Then 450 Wl of
a 2 M NaCl solution and 2 vols. of 96% ethanol were
added for overnight precipitation. After centrifuga-
tion pellets were dried and dissolved in 50 Wl TE
bu¡er (50 mM Tris-HCl, 1 mM EDTA (pH 8.0)).
DNA fragmentation was analyzed on a 1.5% agarose
gel with 5 WM ethidium bromide.
3. Results
3.1. In vivo e¡ects of L-EB, L-PI, and L-DAPI on
Kup¡er cells
Propamidine is e¡ective in the liposome-mediated
macrophage suicide technique in lower doses than
Fig. 1. Kup¡er cells on rat liver sections stained with the
monoclonal antibody ED2. (A) Normal rat liver, animals at 48
h after intravenous injection of 1.5 ml, (B) 500 WM L-DAPI or
(C) 2.5 mM L-EB. Note the absence of ED2-positive cells in B
and the swelling of these cells in C.
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the widely used clodronate [6]. In order to ¢nd other
e¡ective drugs, we focused on the intracellular activ-
ity of compounds structurally related to propami-
dine, i.e. DAPI, PI and EB. In our ¢rst experiment
we injected intravenously 1.5 ml of the liposome sus-
pensions containing various concentrations of DAPI,
PI or EB. While 500 WM L-DAPI (Fig. 1) and 2.5
mM L-PI (not shown) were e¡ective in reducing
numbers of ED2-positive Kup¡er cells, 2.5 mM L-
EB was not (Fig. 1). However, L-EB did a¡ect the
macrophages, which resulted in a swollen shape of
the cells.
As EB, PI and DAPI are all £uorescent dyes,
phagocytosis of the liposome-encapsulated form of
these compounds could be visualized on non-¢xed
liver sections using a £uorescence microscope. Fig.
2 shows a £uorescence image of a liver section of a
rat treated with 500 WM L-PI. The picture is illustra-
tive for treatment with L-PI. Similar pictures (not
shown) were obtained after treatment with 2.5 mM
L-EB and 100 WM L-DAPI. These doses were not
e¡ective in killing Kup¡er cells. The picture clearly
shows the uptake of L-PI.
We studied the e¡ects of administration of these
liposome-encapsulated drugs on the survival of
Kup¡er cells in livers of treated rats and compared
it to the survival after treatment with L-propamidine.
Previously [6], we found that an injection of 2.0 ml
1.0 mM L-propamidine resulted in a more than 50%
reduction of numbers of ED2-positive macrophages.
In Fig. 3 it is shown that 1.5 ml 2.5 mM L-propa-
midine resulted in a 60% decrease in numbers of
ED2-positive cells compared to untreated controls.
Furthermore, of all compounds tested L-DAPI ex-
hibited the highest intracellular toxicity. Even at
500 WM it induced a nearly complete depletion of
ED2-positive Kup¡er cells. On the other hand, L-
EB showed only limited intracellular activity. Inter-
estingly, liposome-encapsulated PI, which is structur-
ally more related to EB than any of the other com-
pounds described here, was roughly 10 times more
e¡ective in eliminating Kup¡er cells than L-EB.
In order to determine the speci¢city of the e¡ects
of the liposome-encapsulated drugs, we also injected
free PI, DAPI and propamidine in a concentration of
50 nmol. On liver sections of these animals we did
not ¢nd di¡erences in ED2 positivity compared to
untreated animals. Also, regarding PI and DAPI,
we were not able to detect £uorescence on non-¢xed
liver sections (data not shown).
3.2. In vitro determination of apoptosis
The £ow cytometrical detection of the appearance
of a sub-G1 peak is a reliable method to determine
programmed cell death [18]. We incubated RAW264
cells with in vivo e¡ective doses of 500 WM L-DAPI
Fig. 2. View on a non-¢xed rat liver section using £uorescence
microscopy. Liver of an animal at 48 h after intravenous ad-
ministration of 500 WM L-PI. This picture clearly shows the up-
take of L-PI.
Fig. 3. E¡ects of various concentrations of 1.5 ml L-drugs on
number of ED2-positive Kup¡er cells. Types of L-drug are in-
dicated in the ¢gure and their e¡ects were determined on rat
liver sections 48 h after intravenous injection. Results of each
concentration of L-drug (n = 4) were correlated with the number
of ED2-positive Kup¡er cells in untreated controls (n = 4),
which was taken as 100% with S.E. = 17.3. Error bars within
each group represent the S.E. as a percentage of the controls (if
S.E.6 10 (W2.5%), error bars are not drawn).
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and 2.5 mM L-PI for 20 h and 72 h. In the case of 25
mM L-EB there are only the results of the 20 h and
48 h incubation, which had already a dramatic e¡ect
on cell viability as determined with trypan blue stain-
ing (results not shown). After even longer incubation
(72 h), only cell debris remained, resulting in noise in
the DNA histograms (not shown). In Fig. 4 the
DNA histograms of the L-DAPI, L-PI and L-EB
treated cells are shown. Untreated cells were taken
as control and exhibited a low percentage of apop-
tosis (about 4%) at both 20 h and 72 h. Similar data
were obtained with PBS liposomes (between 5 and
7%, data not shown). Obviously, L-PI did not induce
apoptosis, neither at 20 h nor at 72 h (Fig. 4). In
addition, relative to the controls, the cultures incu-
bated with L-PI seemed to be una¡ected when cell
numbers and growth were compared. Even after 72 h
no di¡erences could be observed (data not shown
here). In contrary, L-EB had a major e¡ect on the
viability of the cultures. Already after 20 h there was
17% of apoptosis (Fig. 4) and after 48 h the percent-
age of apoptotic cells was still 14%. Trypan blue
staining showed no living cells after 72 h (results
not shown). L-DAPI induced the highest percentage
of apoptosis in this experiment, ranging from 8.7% at
20 h to 50% at 72 h.
To be sure that the appearance of the sub-G1 peak
in the DNA histograms correlates with the oligonu-
cleosomal DNA fragmentation seen during apoptosis
we analyzed the DNA of RAW264 cells incubated
with liposomes by gel electrophoresis. Fig. 5 shows
the agarose gels with DNA of cells treated 20 h with
25 mM L-EB, 72 h with 500 WM L-DAPI or 72 h
with 2.5 mM L-PI. Only L-DAPI induced the DNA
pattern typical for an apoptotic process, con¢rming
the presence of the corresponding (L-DAPI) sub-G1
peak from Fig. 4.
Fig. 4. DNA histograms of control (c) RAW264 cells cultured
for 20 h (20c) and 72 h (72c) without liposomes, and RAW264
cells cultured with 2.5 mM L-PI (p) or 500 WM L-DAPI (d) for
20 h and 72 h (20p, 20d and 72p, 72d respectively). In case of
25 mM L-EB (e) the results of 20 h and 48 h are shown (20e
and 48e). Percentages of apoptotic cells are included in each
histogram.
Fig. 5. Agarose gel electrophoresis of DNA from RAW264 cells
treated with liposome-encapsulated drugs. Lanes A and D show
1 kb DNA ladders, the other lanes show DNA of cells incu-
bated 20 h with 25 mM L-EB (B), 72 h with 500 WM L-DAPI
(C) or 2.5 mM L-PI (E) and DNA of untreated RAW264 cells
(F). Only L-DAPI incubation induced DNA fragmentation.
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3.3. Cytotoxicity of free EB, PI and DAPI
Except for L-EB, all L-drugs so far tested exhib-
ited more intracellular activity in vivo than in vitro.
Contrary, L-EB was more e⁄cacious in vitro than in
vivo. For example, whereas 2.5 mM L-EB was not
capable of depleting Kup¡er cells in vivo (Fig. 3), it
had a major reducing e¡ect on cell numbers in cul-
tures, already after 20 h (results not shown). To in-
vestigate this phenomenon we tested the e¡ects of
free EB, PI and DAPI on cell viability. Fig. 6 shows
these e¡ects for various concentrations. Concentra-
tions of the free drugs in the range of 0.25^2.5 WM
were comparable to the amounts administered in the
corresponding liposome-encapsulated form. (We esti-
mated that 1 ml 2.5 mM L-drug corresponds to
about 1 Wmol of free drug.) It appeared that the
viability as determined by trypan blue staining after
incubation of RAW264 cells with free drug varied
with concentration and type of drug. Free EB led
to the highest reduction in cell numbers. Its e¡ect
was comparable to that of similar liposome-encapsu-
lated amounts (see Section 3). On the other hand,
free DAPI and PI in concentrations comparable to
their liposomal forms had minor e¡ects on cell num-
bers, even after 72 h (data not shown).
In order to ¢nd out whether the cytotoxic e¡ects
of L-EB in vitro are a result of leakage of EB from
liposomes, we determined spectroscopically (V= 280
nm) the amount of free EB after incubation of 100 Wl
liposome suspension in 1 ml culture medium. Al-
ready after 1 h we detected an amount of 0.04
Wmol EB. For L-PI and L-DAPI we could not detect
leakage of drug, even after 24 h incubation.
4. Discussion
The so-called liposome-mediated macrophage sui-
cide approach is based on the selective intracellular
delivery of liposome-encapsulated drugs and its sub-
sequent accumulation in phagocytes [1]. One of the
most frequently used drugs in this technique is clod-
ronate. Especially because of its high hydrophilicity
versus low lipophilicity and its rapid secretion from
the body by the renal system, this bisphosphonate
has the characteristics for proper liposome encapsu-
lation and in vivo use. It will not easily cross lip-
osomal or cellular membranes, so leakage rates will
be low and side e¡ects after administration will be
minimal. In a recent study [19] it has been demon-
strated that the formation of a non-hydrolyzable
ATP metabolite may play an important role in in-
duced cell death by clodronate in macrophage-like
cells. However, until now it is unknown how clod-
ronate exerts its intracellular e¡ects ¢nally leading to
apoptotic cell death in vivo.
Propamidine is an aromatic diamidine with anti-
microbial e¡ects. Like clodronate, it is highly soluble
in water and together with its low lipophilicity it is
well suited for encapsulation in liposomal form. Re-
cently it was found that L-propamidine is even more
active in Kup¡er cell depletion than L-clodronate
and that propamidine, as clodronate, induces apop-
totic cell death [6,7]. As with clodronate, the mode of
intracellular action of propamidine is not known
although its high DNA-binding capacity may play
a major role. This interaction with DNA takes place
mainly at the minor groove and has been investi-
gated in detail [10]. Since L-propamidine exerts its
major intracellular e¡ects probably as a result of its
DNA-binding ability, we decided to investigate the
intracellular activity of the structurally related com-
pound DAPI and the well known DNA-binding
Fig. 6. Cytotoxic e¡ect of free drugs on RAW264 cells. Cell vi-
ability was measured using trypan blue staining and related to
the viability of control RAW264 cells (100%). DAPI, EB, and
PI were tested in four concentrations, as indicated in the ¢gure.
We estimated that in culture the amount of 1 ml 2.5 mM lipo-
some-encapsulated drug corresponds roughly to 1 WM free
drug. Note the di¡erences in e¡ects on cell viability between
DAPI and PI on the one hand and EB on the other at lower
concentrations (0.25^2.5 WM).
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compounds ethidium and propidium, all in liposomal
form.
Like propamidine, DAPI is an aromatic diami-
dine. At low compound to base pair ratios DAPI
binds exclusively to AT base pair sequences in the
minor groove [13,20]. Examining the nature of the
interaction between DAPI and DNA is particularly
relevant considering the development of other se-
quence dependent DNA-binding drugs. Moreover,
unlike propamidine, DAPI is a strong £uorescent
agent, which enables us to determine its localization
after in vivo administration of the liposome-encapsu-
lated form. Two other strong £uorescent dyes are
ethidium bromide and propidium iodide which are
frequently used compounds in staining of DNA.
These two structurally related compounds bind to
DNA in an intercalative fashion and not in the mi-
nor groove [14].
We found L-DAPI to be the most potent drug in
vivo in reducing the number of ED2-positive cells in
the liver. Compared to L-propamidine it is even
about 10 times more e¡ective. Apparently the bind-
ing of a drug to AT sequences in the minor groove of
DNA can be su⁄cient to disturb cell metabolism
eventually leading to cell death. Interestingly, L-PI
reduced numbers of ED2-positive macrophages
more than L-propamidine. It is likely that propidium
will mainly bind DNA after its intracellular release
from the liposome. This intercalative interaction with
DNA, which does not take place in the minor groove
as with DAPI and propamidine, might also be
enough to kill the cell. Since these compounds (PI,
propamidine and DAPI) show only minimal leakage
from liposomes ([21]; this study), variation in the
leakage rates of these three molecules does probably
not explain di¡erences in e⁄cacy. More probably,
di¡erences in DNA binding kinetics or sequence de-
pendence might explain the variation in e⁄cacy. Of
all compounds tested here, L-EB had a markedly low
e¡ect on the presence of ED2-positive cells in the
liver. We have shown here that EB leaks out of lip-
osomes. This probably caused a less e¡ective target-
ing to macrophages. This is supported by our obser-
vations that L-EB showed much more cytotoxic
e¡ects on RAW264 cells in culture than any other
L-drug tested and, moreover, that these e¡ects are
comparable to the ones seen when treating
RAW264 cells with similar amounts of free EB. Re-
cently, a method has been developed to detect leak-
age of ethidium and propidium from PC/cholesterol
liposomes [21]. As in this study, it was found that
propidium has much lower leaking rates than ethidi-
um. This is probably due to the lower lipophilicity of
propidium compared to its hydrophilicity as deter-
mined from the octanol/medium partition coe⁄-
cients.
Furthermore, by making use of the £uorescent
properties of EB, PI, and DAPI it is possible to
demonstrate, on liver sections, the uptake of the lip-
osome-encapsulated form of these drugs. In addition,
to determine the speci¢city of the e¡ects of liposome-
encapsulated drugs in vivo, we analyzed the e¡ects of
injection of free PI, DAPI and propamidine on ED2
positivity. On liver sections, we could not ¢nd di¡er-
ences in ED2 positivity when compared to untreated
animals. Also, regarding PI and DAPI, we could not
detect £uorescence on non-¢xed sections. Altogether,
these results demonstrate the speci¢city of the in vivo
e¡ects of liposome-encapsulated DAPI and propami-
dine on Kup¡er cells. So, for diamidines like DAPI
and propamidine but also for propidium iodide, lip-
osomes are suitable carriers to target these drugs to
macrophages and may very well be used to suppress
toxic side e¡ects. Moreover, encapsulation allows us
to compare the intracellular activity of related com-
pounds. For instance, the results from our experi-
ments indicate that DAPI has about 10-fold higher
intracellular activity than propamidine.
We clearly demonstrated that L-DAPI, like L-
propamidine [7], induced apoptotic cell death in mac-
rophage-like RAW264 cells. Although L-EB also in-
duced a sub-G1 peak on the DNA histogram, we
were unable to show DNA fragmentation on an
agarose gel. However, the high reduction of cell via-
bility, as determined with trypan blue staining, after
incubation of cells with L-EB clearly demonstrated
cell death. Earlier it was stated that a rapid process
of cell death will favor necrosis [22]. We argue that
cell death induced by L-EB in vitro is a fast process
and that L-EB induces at least for a part necrotic cell
death. Because EB can traverse membrane structures
easily, uptake of EB in culture by the target cell can
be regarded as liposome independent. In other
words, endocytosis of liposomes is not a key step
in the intracellular accumulation of EB. Therefore,
in vitro EB will probably accumulate in the target
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cell more rapidly than drugs that are dependent on
liposomes for their uptake (e.g. PI and DAPI). This
makes sense when taking into account relatively slow
processes as receptor mediated phagocytosis and ly-
sosomal degradation of liposomal components pre-
ceding the intracellular release of free drug. It ex-
plains the relatively delayed e¡ects of L-DAPI on
RAW cells in culture compared to L-EB.
In general, we conclude that in view of the leakage
from liposomes and capacity to traverse biomem-
branes, DAPI and PI, but not EB are suitable for
labeling of liposomes or use in the liposome-medi-
ated macrophage ‘suicide’ technique.
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